Literature DB >> 24351614

Absence seizures in children.

Ewa Posner1.   

Abstract

INTRODUCTION: About 10% of seizures in children with epilepsy are typical absence seizures. Absence seizures have a significant impact on quality of life. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical question: What are the effects of treatments for typical absence seizures in children? We searched: Medline, Embase, The Cochrane Library, and other important databases up to July 2013 (Clinical Evidence reviews are updated periodically; please check our website for the most up to date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 18 RCTs or systematic reviews of RCTs that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: clonazepam, ethosuximide, gabapentin, lamotrigine, and valproate.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24351614      PMCID: PMC3867171     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  19 in total

1.  Valproic acid versus ethosuximide in the treatment of absence seizures.

Authors:  S Sato; B G White; J K Penry; F E Dreifuss; J C Sackellares; H J Kupferberg
Journal:  Neurology       Date:  1982-02       Impact factor: 9.910

2.  Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal).

Authors:  N Callaghan; J O'Hare; D O'Driscoll; B O'Neill; M Daly
Journal:  Dev Med Child Neurol       Date:  1982-12       Impact factor: 5.449

3.  Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months.

Authors:  Tracy A Glauser; Avital Cnaan; Shlomo Shinnar; Deborah G Hirtz; Dennis Dlugos; David Masur; Peggy O Clark; Peter C Adamson
Journal:  Epilepsia       Date:  2012-11-21       Impact factor: 5.864

4.  Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.

Authors:  Giangennaro Coppola; Gianfranca Auricchio; Rosario Federico; Marco Carotenuto; Antonio Pascotto
Journal:  Epilepsia       Date:  2004-09       Impact factor: 5.864

Review 5.  Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Authors:  J A French; A M Kanner; J Bautista; B Abou-Khalil; T Browne; C L Harden; W H Theodore; C Bazil; J Stern; S C Schachter; D Bergen; D Hirtz; G D Montouris; M Nespeca; B Gidal; W J Marks; W R Turk; J H Fischer; B Bourgeois; A Wilner; R E Faught; R C Sachdeo; A Beydoun; T A Glauser
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

Review 6.  Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.

Authors:  Tracy Glauser; Elinor Ben-Menachem; Blaise Bourgeois; Avital Cnaan; Carlos Guerreiro; Reetta Kälviäinen; Richard Mattson; Jacqueline A French; Emilio Perucca; Torbjorn Tomson
Journal:  Epilepsia       Date:  2013-01-25       Impact factor: 5.864

7.  Lamotrigine for the treatment of epilepsy in childhood.

Authors:  F M Besag; S J Wallace; O Dulac; J Alving; S C Spencer; G Hosking
Journal:  J Pediatr       Date:  1995-12       Impact factor: 4.406

8.  Lamotrigine in treatment of 120 children with epilepsy.

Authors:  E Schlumberger; F Chavez; L Palacios; E Rey; N Pajot; O Dulac
Journal:  Epilepsia       Date:  1994 Mar-Apr       Impact factor: 5.864

Review 9.  The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy. A systematic review.

Authors:  M Connock; E Frew; B-W Evans; S Bryan; C Cummins; A Fry-Smith; A Li Wan Po; J Sandercock
Journal:  Health Technol Assess       Date:  2006-03       Impact factor: 4.014

10.  Carbamazepine-exacerbated epilepsy in children and adolescents.

Authors:  C S Horn; S B Ater; D L Hurst
Journal:  Pediatr Neurol       Date:  1986 Nov-Dec       Impact factor: 3.372

View more
  2 in total

1.  Spontaneous Recurrent Absence Seizure-like Events in Wild-Caught Rats.

Authors:  Jeremy A Taylor; Jon D Reuter; Rebecca A Kubiak; Toni T Mufford; Carmen J Booth; F Edward Dudek; Daniel S Barth
Journal:  J Neurosci       Date:  2019-04-10       Impact factor: 6.167

2.  Dysfunction of parvalbumin-expressing cells in the thalamic reticular nucleus induces cortical spike-and-wave discharges and an unconscious state.

Authors:  Manal S Abdelaal; Mitsuharu Midorikawa; Toru Suzuki; Kenta Kobayashi; Norio Takata; Mariko Miyata; Masaru Mimura; Kenji F Tanaka
Journal:  Brain Commun       Date:  2022-01-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.